Perhaps, smart glioma-targeting nanoplatforms (Ahmad et al. 2022) might aid in enhancing the specific targeting of this dominant negative HOTAIR mutant to glioma sites in human cases. This evidence concerns the gene HOTAIR and central nervous system cancer.